Hepatitis C Module #1: The abCs of HCV

Module One will address the epidemiology, diagnosis, and pathophysiology of HCV. Staging of HCV will also be reviewed. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Hepatitis C Module #2: Direct Acting Antivirals for the Treatment of Hepatitis C

Module Two will discuss the evolution of HCV treatments and the pharmacology of current agents. Possible drug interactions will also be reviewed. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Hepatitis C Module #3: HCV Drug Therapy Management

Module Three will address patient specific factors, treatment options, and the monitoring of HCV treatments. Pharmacist interventions will also be discussed. This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Hepatitis C Module #4: Treatment of HCV in Special Populations, HCV Resistance, and the Future of HCV Therapy

Module Four will include appropriateness of therapy for special populations, resistance issues, and emerging treatment options. The role of the specialty pharmacist will also be addressed. This activity is available for free to NASP members. Visit the top section of www.ProCE.com/CSPE for details.

High-Alert Medications Heparin, Concentrated Electrolytes, and Magnesium: Practical Strategies in Pursuit of Safety

Join the ISMP faculty as we focus particular attention on the potential safe use risks with heparin, concentrated electrolytes, and magnesium using the results from ISMP Medication Safety Self Assessment® for High-Alert Medications.

High-Alert Medications Insulin and Vasopressors: Practical Strategies in Pursuit of Safety

Join the ISMP faculty as we examine and define the importance of high-alert medications as part of routine patient care and review the results of ISMP Medication Safety Self Assessment® for High-Alert Medications with particular attention to vasopressors and insulin.

IBD: Medication and Patient Management

This activity addresses treatment goals, options for therapy, monitoring parameters and the pharmacist's role in IBD therapy management.

Incorporating the Newest CLSI Recommendations for Antimicrobial Susceptibility Testing into your Stewardship Activities

This annual webcast that provides updates on hot topics related to antibiotic stewardship and microbiological testing. This year’s webcast includes recent CLSI antimicrobial susceptibility testing updates for gram positive/gram negative bacteria and Candida species.

Management of Anticoagulant-Related Major Bleeding: Clinical Updates and Best Practices for Health-System Pharmacists

This activity will improve the knowledge and competence of pharmacists about the management of anticoagulant-related bleeding, including recent guideline updates, selecting appropriate reversal agents and dosing strategies.

Management of Peanut Allergy

This presentation discusses the prevalence, pathophysiology, and epidemiology for IgE-mediated food allergy with a special focus on peanut allergy. Available for free to NASP members. Visit www.ProCE.com/CSPE for details.